haloperidol has been researched along with rbi 257 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hopkins, CR; Lindsley, CW | 1 |
Bakthavachalam, V; Baldessarini, RJ; Kula, NS; Pounds, S; Tarazi, FI; True, CD; Xu, L | 1 |
1 review(s) available for haloperidol and rbi 257
Article | Year |
---|---|
Return of D
Topics: Animals; Drug Discovery; Humans; Ligands; Molecular Targeted Therapy; Neoplasms; Parkinson Disease; Receptors, Dopamine D4; Small Molecule Libraries; Substance-Related Disorders | 2017 |
1 other study(ies) available for haloperidol and rbi 257
Article | Year |
---|---|
Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands.
Topics: Aminopyridines; Animals; Binding, Competitive; Cell Membrane; CHO Cells; Cricetinae; Dopamine Agents; Dopamine Antagonists; Haloperidol; Humans; In Vitro Techniques; Ligands; Male; Piperidines; Prosencephalon; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D4; Spiperone; Tritium | 1999 |